P
HALO icon

&Partners’s Halozyme HALO Stock Holding History

&Partners’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$887K Buy
11,335
+5,776
+104% +$394K ﹤0.01% 1486
2026
Q1 		$358K Sell
5,559
-263
-5% -$18.5K ﹤0.01% 1877
2025
Q4 		$392K Sell
5,822
-976
-14% -$65.7K ﹤0.01% 1758
2025
Q3 		$499K Sell
6,798
-68
-1% -$4.52K ﹤0.01% 1439
2025
Q2 		$355K Sell
6,866
-7,064
-51% -$402K ﹤0.01% 1532
2025
Q1 		$894K Buy
13,930
+4,215
+43% +$245K 0.01% 878
2024
Q4 		$464K Buy
9,715
+6,000
+162% +$308K 0.01% 1106
2024
Q3 		$213K Buy
+3,715
New +$213K ﹤0.01% 1278

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

&Partners's HALO Position: Q2 2026 in Review

&Partners increased its Halozyme (HALO) stake by 104% in Q2 2026, buying an estimated $394K and bringing the position to 11,335 shares worth $887K. The position accounts for ﹤0.01% of the portfolio, ranked #1486.

&Partners first reported a position in HALO in Q3 2024 and has held it in 8 quarters since. The position peaked at $894K in Q1 2025. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • &Partners held 11,335 shares of Halozyme worth $887K as of Q2 2026.
  • &Partners bought 5,776 Halozyme shares in Q2 2026, an estimated $394K.
  • Halozyme made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1486 holding.
  • &Partners first reported a position in Halozyme in Q3 2024 and has held it in 8 quarters since.
  • &Partners's Halozyme position peaked at $894K in Q1 2025.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.